Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
Background: Anti-staphylococcal penicillins have long been the first-line treatment option for methicillin-susceptible Staphylococcus aureus (MSSA) infections. Recent retrospective data comparing nafcillin and cefazolin report similar clinical efficacy despite concerns about high inoculum MSSA infec...
Main Authors: | Marguerite L. Monogue, Jessica K. Ortwine, Wenjing Wei, Khalid Eljaaly, Kavita P. Bhavan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-09-01
|
Series: | Journal of Infection and Public Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034118300297 |
Similar Items
-
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible <it>Staphylococcus aureus </it>bacteremia
by: McGregor Jessina C, et al.
Published: (2011-10-01) -
A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections
by: Matthew A. Miller, et al.
Published: (2020-04-01) -
Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
by: Benjamin H. Gern, et al.
Published: (2018-02-01) -
Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study
by: Dong Hyun Oh, et al.
Published: (2018-01-01) -
Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis
by: Changcheng Shi, et al.
Published: (2018-10-01)